Company Overview

Development Stage

About the Company

[Summary] 致力于发现并开发治疗耐药性细菌感染的更加安全和便利的抗菌药

Better Therapy Through Superior Medicines以良药求良效
盟科医药致力于发掘和开发能满足患者特殊需求的更高质量的新型抗感染药物,并在未来实现其生产和商业化。
盟科医药在美国旧金山湾区和上海的张江高科技园区设有研发中心,由一支富有经验和成功记录的专家队伍组成,其核心研发科学家和管理人员均在美国创新药物开发及管理领域拥有十几年以上的实际工作经验,是世界医药工业界公认的开发新型抗生素领域的权威。
公司的资金投资方是晨兴创投---一家成功的从事高科技风险投资的机构。晨兴创投致力于帮助初创和成长型高科技企业,不仅向创业者们提供长期的风险投资,而且还向他们提供管理支持,创业者们也可以分享晨兴集团在全球的商业网络和合作伙伴。
盟科医药愿把国际一流的创新药物研发技术引入中国,公司正在上海张江高科技园区建立一个具有从确定课题、发掘新药到测定药效的多功能创新药物研发基地。我们恳请有经验的药物研发和管理人才加入盟科,共同组建这一独特的创新药物综合研发基地。
盟科医药将以睿智、创新、务实的态度,推进公司的不断成长。现在正逢盟科大量招贤纳才之时,此次广发英雄贴,我们恳请有经验的药物研发和管理人才加入盟科,共同组建这一独特的创新药物综合研发基地。
请有兴趣的人才尽快与我们取得联系,我们将在*短的时间内对经过初步删选符合条件的人才约定面试!并感谢所有投简历的人才对盟科的认可和支持!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

盟科医药 Financing History (2 rounds)

Manage
D轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 1亿人民币
  • Investor: 德联资本,百奥财富

盟科医药 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 3,731.875万(元)
Legal Representative: 王星海
Date Established:
Credit Code: 9131011566432944XY
Registered Address: 中国(上海)自由贸易试验区爱迪生路53号1幢地下1层01-1

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates